Skip to main content
. 2024 May 31;13(6):513. doi: 10.3390/antibiotics13060513
AI Artificial intelligence
ACS Acute coronary syndrome
AHA American Heart Association
AMI Acute myocardial infarction
AMR Antimicrobial resistance
CAD Coronary artery disease
CAMA Coronary artery mycotic aneurysm
CT Computed tomography
DES Drug-eluting stents
EE Embolic events
ESC European Society of Cardiology
IE Infective endocarditis
GD Graves’ disease
HF Heart failure
IBD Inflammatory bowel disease
JACC Journal of the American College of Cardiology
IVDA Intravenous drug abusers
LAD Anterior descending artery
LCX Left coronary circumflex artery
LMCA Left main coronary artery
LSE Libman–Sacks endocarditis
MIC Minimum inhibitory concentration
MRI Cardiac magnetic resonance
MRSA Methicillin-resistant Staphylococcus aureus
MS Multiple sclerosis
MSSA Methicillin-susceptible Staphylococcus aureus
NSTEMI NON-ST elevation myocardial infarction
NVE Native valve endocarditis
PREMs Patient-reported Experience Measures
PROMs Patient-reported Outcome Measures
PVE Prosthetic valve endocarditis
RA Rheumatoid arthritis
RCA Right coronary artery
SLE Systemic lupus erythematosus
STEMI ST elevation myocardial infarction
TDM Therapeutic drug monitoring
TOE Transesophageal cardiac ultrasound
TTE Transthoracic cardiac ultrasound
T1D Type 1 diabetes
T2D Type 2 diabetes
UI Uncontrolled infection
WHO World Health Organization